Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

recurrent adult acute myeloid leukemia

Known as: Recurrent Adult AML, leukemia, relapsed adult acute myeloid, leukemia, relapsed adult acute myelogenous 
The reemergence of acute myeloid leukemia in adults after a period of remission.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract The CLL-IPI is a risk-weighted prognostic model for previously untreated patients with chronic lymphocytic leukemia (CLL… Expand
Is this relevant?
2015
2015
AbstractThe aim of this study was to investigate the role of microRNA-335 (miR-335) in determining the treatment response and… Expand
Is this relevant?
Review
2012
Review
2012
Objective:To summarize the therapy strategies for relapsed adult acute myeloid leukemia(AML) with MLL gene arrangement after… Expand
Is this relevant?
2010
2010
BACKGROUND Colorectal cancer (CRC) patients whose tumours have microsatellite instability (MSI) do not benefit from adjuvant 5… Expand
Is this relevant?
2008
2008
A large proportion of adult patients with acute myeloid leukemia (AML) relapse after treatment, and some of them are resistant to… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2007
2007
BACKGROUND Bortezomib is an inhibitor of proteasome and NF-kappaB, with activity in various solid tumors and hematological… Expand
  • table I
Is this relevant?
2004
2004
Background : High-dose cytarabine (HDAC) and etoposide, two of the most active drugs in relapsed acute myeloid leukemia (AML… Expand
Is this relevant?
Review
2002
Review
2002
Main chemotherapy regimens used to treat adult patients with acute myeloid leukemia (AML) in first or further relapse were… Expand
Is this relevant?
1999
1999
BACKGROUND AND OBJECTIVE High-dose cytarabine (HDAra-C), mitoxantrone and etoposide are the mainstay of several active regimens… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?